Coexpression of MUC1 mucin peptide core and the thomsen-friedenreich antigen in colorectal neoplasms

Cancer

Volumn 82, Issue 6, 1998, Pages 1019-1027

  Baldus, Stephan E ^a   Hanisch, Franz Georg ^a   Kotlarek, Georg M ^a   Zirbes, Thomas K ^a   Thiele, Juergen ^a   Isenberg, Joerg ^a   Karsten, Uwe R ^b   Devine, Peter L ^c   Dienes, Hans P ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Colorectal carcinoma; Monoclonal antibody; Mucin; Thomsen Friedenreich antigen; Tumor associated antigen

Indexed keywords

MONOCLONAL ANTIBODY; MUCIN; TUMOR ANTIGEN;

ADENOMA; ANTIGEN EXPRESSION; ARTICLE; CANCER GROWTH; COLORECTAL CANCER; COLORECTAL CARCINOMA; DYSPLASIA; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MUCINOUS CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOCARCINOMA; ANTIBODIES, MONOCLONAL; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CA-15-3 ANTIGEN; CARCINOMA; COLORECTAL NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; HUMANS; IMMUNOHISTOCHEMISTRY; MUCINS;

EID: 0032521020     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980315)82:6<1019::AID-CNCR3>3.0.CO;2-9     Document Type: Article

References (46)

1. Thomsen O. Ein vermehrungsfähiges Agens als Veränderer des isoagglutinatorischen Verhaltens der roten Blutkörperchen, eine bisher unbekannte Quelle der Fehlbestimmungen. Z Immun-Forsch 1927;52:85-107.
2. Friedenreich V. The Thomsen hemagglutination phenomenon. Copenhagen: Levin & Munksgaard, 1930.
3. Springer GF. T and Tn, general carcinoma antigens. Science 1984;224:1198-206.
4. Hanisch FG, Baldus SE. The Thomsen-Friedenreich (TF) antigen: a critical review on the structural, biosynthetic and histochemical aspects of a pancarcinoma-associated antigen. Histol Histopathol 1997;12:263-81.
5. Uhlenbruck G, Pardoe GI, Bird GWG. On the specificity of lectins with a broad agglutination spectrum. II. Studies on the nature of the T-antigen and the specific receptors for the lectin from Arachis hypogaea (ground nut). Z. Immun-Forsch 1969;138:423-33.
6. Lotan R, Skutelsky E, Danon D, Sharon H. The purification, composition, and specificity of the anti-T lectin from peanut (Arachis hypogaea). J Biol Chem 1975;250:8518-23.
7. Cao Y, Stosiek P, Springer GF, Karsten U. Thomsen-Friedenreich-related carbohydrate antigens in normal adult human tissues: a systematic and comparative study. Histochem Cell Biol 1996;106:197-207.
8. Klein PJ, Osmers R, Vierbuchen M, Ortmann M, Kania J, Uhlenbruck G. The importance of lectin binding sites and carcinoembryonic antigen with regard to normal, hyperplastic, adenomatous, and carcinomatous colonic mucosa. Rec Res Cancer Res 1981;79:1-9.
9. Boland RC, Montgomery CK, Kim YS. Alterations in human colonic mucin occurring with cellular differentiation and malignant transformation. Proc Natl Acad Sci U S A 1982;79:2051-5.
10. Cooper HS. Peanut lectin-binding sites in large bowel carcinoma. Lab Invest 1982;47:383-90.
11. Cooper HS, Reuter VE. Peanut lectin-binding sites in polyps of the colon and rectum. Lab Invest 1983;49:655-61.
12. Kellokumpu I, Karhi K, Andersson LC. Lectin-binding sites in normal, hyperplastic, adenomatous and carcinomatous human colorectal mucosa. APMIS 1986;94:271-80.
13. Rhodes JM, Black RR, Savage A. Glycoprotein abnormalities in colonic carcinomata, adenomata, and hyperplastic polyps shown by lectin peroxidase histochemistry. J Clin Pathol 1986;39:1331-4.
14. Campo E, Condom E, Palacin A, Quesada E, Cardesa A. Lectin binding patterns in normal and neoplastic colonic mucosa. Dis Colon Rectum 1988;31:892-9.
15. Caldero J, Campo E, Ascaso C, Ramos R, Panades MJ, Rene JM. Regional distribution of glycoconjugates in normal, transitional and neoplastic colonic mucosa. Virchows Archiv A Pathol Anat 1989;415:347-56.
16. McGarrity TJ, Pfeifer LP, Abt AB. Lectin histochemistry of adenomatous polyps. Cancer 1989;64:1708-13.
17. Orntoft TF, Langkilde NC, Wiener H, Ottosen PD. Cellular localization of PNA binding in colorectal adenomas: comparison with differentiation, nuclear:cell height ratio and effect of desialylation. APMIS 1991;99:275-81.
18. Yuan M, Itzkowitz SH, Boland CR, Kim YD, Tomita JT, Palekar A, et al. Comparison of T-antigen expression in normal, premalignant, and malignant human colonic tissue using lectin and antibody immunohistochemistry. Cancer Res 1986;46:4841-7.
19. Itzkowitz SH, Yuan M, Montgomery CK, Kjeldsen T, Takahashi HK, Bigbee WL, et al. Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer. Cancer Res 1989;49:197-204.
20. Cao Y, Karsten UR, Liebrich W, Haensch W, Springer GF, Schlag PM. Expression of Thomsen-Friedenreich-related antigens in primary and metastatic colorectal carcinomas: a reevaluation. Cancer 1995;76:1700-8.
21. Neurohr KJ, Bundle DR, Young NM, Mantsch HH. Binding of disaccharides by peanut agglutinin as studied by ultraviolet difference spectroscopy. Eur J Biochem 1982; 123:305-10.
22. Hanisch FG, Stadie T, Bosslet K. Monoclonal antibody BW835 defines a site-specific Thomsen-Friedenreich disaccharide linked to threonine within the VTSA motif of MUC1 tandem repeats. Cancer Res 1995;55:4036-40.
23. Granovsky M, Bielfeldt T, Peters S, Paulsen H, Meldal M, Brockhausen J, et al. UDPgalactose:glycoprotein-N-acetyl-D-galactosamine 3-β-D-galactosyltransferase activity synthesizing O-glycan core 1 is controlled by the amino acid sequence and glycosylation of glycopeptide structures. Eur J Biochem 1994;221:1039-46.
24. Taylor-Papadimitriou J. Report on the First International Workshop on carcinoma-associated mucins. Int J Cancer 1991;49:1-5.
25. Karsten U, Butschak G, Cao Y, Goletz S, Hanisch FG. A new monoclonal antibody (A78-G/A7) to the Thomsen-Friedenreich pan-tumor antigen. Hybridoma 1995;14:37-44.
26. Devine PL, McGuckin MA, Birrell GW, Whitehead RH, Sachdev GP, Shield P, et al. Monoclonal antibodies reacting with the MUC2 mucin core protein. Br J Cancer 1993;67:1182-8.
27. Burchell J, Durbin H, Taylor-Papadimitriou J. Complexity of expression of antigenic determinants, recognised by monoclonal antibodies HMFG-1 and HMFG-2, in normal and malignant human mammary epithelial cells. J Immunol 1983;131:508-13.
28. x antigen as defined by monoclonal antibody AM-3 is a marker of dysplasia in the colonic adenoma-carcinoma sequence. Cancer Res 1992;52:3138-44.
29. Meijer GA, Meuwissen SG, Baak JP. Classification of colorectal adenomas with quantitative pathology: evaluation of morphometry, stereology, mitotic counts and syntactic structure analysis. Anal Cell Pathol 1995;9:311-23.
30. Itzkowitz SH, Bloom EJ, Lau TS, Kim YS. Mucin associated Tn and sialosyl-Tn antigen expression in colorectal polyps. Gut 1992;33:518-23.
31. Hanski C, Bornhoeft G, Topf N, Hermann U, Stein H, Riecken EO. Detection of a mucin marker for the adenoma-carcinoma sequence in human colonic mucosa by monoclonal antibody AM-3. J Clin Pathol 1990;43:379-84.
32. Hanisch FG, Heimbüchel G, Baldus SE, Uhlenbruck G, Schmits R, Pfreundschuh M, et al. Monoclonal antibody FW6 defines an epitope on α3/4-monofucosylated polylactosaminoglycans expressed by fetal and colon carcinoma-associated mucins. Cancer Res 1993;53:4367-75.
33. Baldus SE, Vierbuchen M, Hanisch FG, Schwonzen M, Fischer R. Expression of alpha-3/4-monofucosylated polylactosaminoglycan epitope as defined by monoclonal antibody FW6 is a marker of the colorectal adenoma-carcinoma sequence. Cancer 1995;76:954-60.
34. Ogata S, Uehara H, Chen A, Itzkowitz SH. Mucin gene expression in colonic tissues and cell lines. Cancer Res 1992;52:5971-8.
35. Blank M, Klussmann E, Krüger-Krasakages S, Schmitt-Gräff A, Stolte M, Bornhoeft G, et al. Expression of MUC2-mucin in colorectal adenomas and carcinomas of different histological types. Int J Cancer 1994;59:301-6.
36. Hanski C. Is mucinous carcinoma of the colorectum a distinct genetic entity? Br J Cancer 1995;72:1350-6.
37. Ashwell G, Morell AG. The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins. Adv Enzymol 1974;41:99-128.
38. Kolb-Bachofen V, Schlepper-Schäfer J, Vogell W, Kolb H. Electron microscopic evidence for an asialoglycoprotein receptor on Kupffer cells: localization of lectin-mediated endocytosis. Cell 1982;29:859-66.
39. Springer GF, Cheinsong-Popov R, Schirrmacher V, Desai PR, Tegtmeyer H. Proposed molecular basis of murine tumor cell-hepatocyte interaction. J Biol Chem 1983; 258:5702-6.
40. Beuth J, Ko HL, Schirrmacher V, Uhlenbruck G, Pulverer, G. Inhibition of liver tumor cell colonisation in two animal tumor models by lectin blocking with D-galactose or arabinogalactan. Clin Exp Metastas 1988;6:115-20.
41. Yeatman TJ, Blank KI, Copeland EM III, Kimura AK. Tumor cell surface galactose correlates with the degree of colorectal liver metastasis. J Surg Res 1989;46:567-71.
42. Campbell BJ, Finnie IA, Hounsell EF, Rhodes JM. Direct demonstration of Thomsen-Friedenreich (TF) antigen in colonic adenocarcinoma and ulcerative colitis mucin and its concealment in normal mucin. J Clin Invest 1995;95:571-6.
43. Yang JM, Byrd JC, Siddiki BB, Chung YS, Okuno M, Sowa M, et al. Alterations in O-glycan biosynthesis in human colon cancer tissues. Glycobiology 1994;4:873-84.
44. Vavasseur F, Dole K, Yang J, Malta KL, Myerscough N, Corfield A, et al. O-glycan biosynthesis in human colorectal adenoma cells during progression to cancer. Eur J Biochem 1994;222:415-24.
45. King MJ, Chan A, Roe R, Warren BF, Dell A, Morris HR, et al. Two different glycosyltransferase defects that result in GalNAcα-O-peptide (Tn) expression. Glycobiology 1994;4: 267-79.
46. Xing PX, Apostopoulos V, Prenzoska J, Devine PL, McKenzie IFC. Peptide binding sites recognized by anti-mucin (MUC2) monoclonal antibodies. Scand J Immunol 1993;38:591-2.